The University of Toledo Medical Center will transition to a new leader June 1 following an announcement by UT President Sharon L. Gaber Tuesday that Dave Morlock, CEO of UTMC and executive vice president, will leave the institution for a new opportunity based in New York.
Dan Barbee, vice president for clinical services, has been named UTMC’s interim CEO and will report to Dr. Christopher Cooper, executive vice president for clinical affairs and dean of the College of Medicine and Life Sciences.
“Under Dave’s leadership, UTMC’s patient care quality, patient satisfaction, market share and finances have improved significantly,” Gaber said. “Additionally, Dave has aligned UTMC well for success indicated by next year’s financial and patient measures.”
Greg Hawkins, director of business development, will be taking on a larger role at UTMC, as well as with the implementation of the affiliation agreement.
Gaber, who will remain directly involved with decisions regarding the hospital’s operation and future, said a national search will be conducted for a permanent CEO.
“I want to wish Dave much success, and I am grateful for all he has done as CEO,” Gaber said. “UTMC remains committed to outstanding health care, patient safety and patient satisfaction.”
